CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 38 filers reported holding CYTEIR THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $4,111,995 | -19.0% | 2,492,118 | -5.7% | 0.02% | -24.2% |
Q3 2022 | $5,076,000 | -35.8% | 2,643,640 | 0.0% | 0.03% | -26.7% |
Q2 2022 | $7,904,000 | +158.0% | 2,643,640 | +225.3% | 0.04% | +150.0% |
Q1 2022 | $3,064,000 | -66.8% | 812,640 | 0.0% | 0.02% | -60.0% |
Q4 2021 | $9,240,000 | -35.2% | 812,640 | 0.0% | 0.04% | -28.6% |
Q3 2021 | $14,262,000 | -18.0% | 812,640 | 0.0% | 0.06% | -17.1% |
Q2 2021 | $17,390,000 | – | 812,640 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OUP Management Co., LLC | 2,459,572 | $6,985,184 | 15.71% |
BML Capital Management, LLC | 3,250,008 | $9,230,023 | 8.48% |
Newtyn Management, LLC | 2,500,444 | $7,101,261 | 1.75% |
VR Advisory Services Ltd | 1,072,968 | $3,047,229 | 1.08% |
Anson Funds Management LP | 1,324,114 | $3,760,484 | 0.76% |
Acuitas Investments, LLC | 329,164 | $934,826 | 0.55% |
Aldebaran Capital, LLC | 143,739 | $408,219 | 0.42% |
Bulldog Investors, LLP | 200,000 | $568,000 | 0.20% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 416,200 | $1,182,008 | 0.19% |
Alta Fundamental Advisers LLC | 117,346 | $333,263 | 0.16% |